Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze

Behavioural Brain Research

Volumn 207, Issue 1, 2010, Pages 112-117

  Calixto, A V ^a   Duarte, F S ^a   Duzzioni, M ^a   Nascimento Hackl L P ^a   Faria, M S ^a   De Lima, T C M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Conditioned and unconditioned fear; Nitric oxide; Ventral hippocampus

Indexed keywords

7 NITROINDAZOLE; CYCLIC GMP; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ANXIETY DISORDER; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DRUG INHIBITION; ESCAPE BEHAVIOR; FEAR; HIPPOCAMPUS; LATENT PERIOD; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; PANIC; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESCAPE REACTION; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; INDAZOLES; MALE; METHYLENE BLUE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; RATS; RATS, WISTAR; STAINING AND LABELING;

EID: 70849091774     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.09.037     Document Type: Article

References (68)

1. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 357 3 (2001) 593-615
2. Archer S.L., and Hampl V. NG-monomethyl-l-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem Biophys Res Commun 188 2 (1992) 590-596
3. Bannerman D.M., Grubb M., Deacon R.M., Yee B.K., Feldon J., and Rawlins J.N. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139 1-2 (2003) 197-213
4. Bannerman D.M., McHugh S.B., Deacon R.M., and Rawlins J.N. Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci 118 1 (2004) 63-78
5. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28 3 (2004) 273-283
6. Beijamini V., and Guimarães F.S. Activation of neurons containing the enzyme nitric oxide synthase following exposure to an elevated plus maze. Brain Res Bull 69 (2006) 347-355
7. Bertoglio L.J., Joca S.R., and Guimarães F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 175 (2006) 183-188
8. Blanchard R.J., and Blanchard D.C. Effects of hippocampal lesions on the rat's reaction to a cat. J Comp Physiol Psychol 78 1 (1972) 77-82
9. Blanchard R.J., Blanchard D.C., Takahashi T., and Kelley M.J. Attack and defensive behaviour in the albino rat. Anim Behav 25 3 (1977) 622-634
10. Burwell R.D., Witter M.P., and Amaral D.G. Perirhinal and postrhinal cortices of the rat: a review of the neuroanatomical literature and comparison with findings from the monkey brain. Hippocampus 5 5 (1995) 390-408
11. Calfa G., Bussolino D., and Molina V.A. Involvement of the lateral septum and the ventral hippocampus in the emotional sequelae induced by social defeat: role of glucocorticoid receptors. Behav Brain Res 181 1 (2007) 23-34
12. Calixto A.V., Duarte F.S., Moraes C.K., Faria M.S., and De Lima T.C. Nitric oxide involvement and neural substrates of the conditioned and innate fear as evaluated in the T-maze test in rats. Behav Brain Res 189 2 (2008) 341-349
13. Calixto A.V., Vandresen N., De Nucci G., Moreno H., and Faria M.S. Nitric oxide may underlie learned fear in the elevated T-maze. Brain Res Bull 55 (2001) 37-42
14. Canteras N.S. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol Biochem Behav 71 3 (2002) 481-491
15. Cappendijk S.L., Duval S.Y., de Vries R., and Dzoljic M.R. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neurosci Lett 183 1-2 (1995) 67-70
16. Chiavegatto S., Scavone C., and Canteras N.S. Nitric oxide synthase activity in the dorsal periaqueductal gray of rats expressing innate fear responses. Neuroreport 9 4 (1998) 571-576
17. Czech D.A., Kazel M., and Harris J. A nitric oxide synthesis inhibitor, NG-nitro-l-arginine methyl ester attenuates lipoprivic feeding in mice. Physiol Behav 80 (2003) 75-79
18. Degroot A., and Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Res 1001 1-2 (2004) 60-71
19. Del Bel E.A., da Silva C.A., Guimarães F.S., and Bermúdez-Echeverry M. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats. Eur J Pharmacol 485 1-3 (2004) 175-181
20. Del Bel E.A., Guimarães F.S., Echeverry M.B., Gomes M.Z., Souza A.S., Padovan-Neto F.E., et al. Role of nitric oxide on motor behavior. Cell Mol Neurobiol 25 (2005) 371-392
21. De Oliveira R.W., Del Bel E.A., and Guimarães F.S. Effects of excitatory amino acids and nitric oxide on flight behavior elicited from the dorsal periaqueductal gray. Neurosci Biobehav Rev 25 (2001) 679-685
22. De Oliveira R.W., and Guimarães F.S. Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter. Braz J Med Biol Res 32 12 (1999) 1529-1532
23. Dun N.J., Dun S.L., Wong R.K., and Förstermann U. Colocalization of nitric oxide synthase and somatostatin immunoreactivity in rat dentate hilar neurons. Proc Natl Acad Sci U S A 91 (1994) 2955-2959
24. Echeverry M.B., Guimarães F.S., and Del Bel E.A. Acute and delayed restraint stress-induced changes in nitric oxide producing neurons in limbic regions 125 4 (2004) 981-993
25. Engin E., and Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 18 5-6 (2007) 365-374
26. Faria M.S., Muscara M.N., Moreno Jr. H., Teixeira S.A., Dias H.B., Graeff F.G., et al. Acute inhibition of the l-Arginine/nitric oxide pathway induces anxiolysis in the elevated plus-maze test. Eur J Pharmacol 323 (1997) 91-94
27. Ferreira V.M., Valenzuela C.F., and Morato G.S. Role of nitric oxide-dependent pathways in ethanol-induced anxiolytic effects in rats. Alcohol Clin Exp Res 23 12 (1999) 1898-1904
28. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66 1 (2000) 65-72
29. Förstermann U., Schmidt H.H., Pollock J.S., Sheng H., Mitchell J.A., and Warner T.D. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42 10 (1991) 1849-1857
30. Graeff F.G., Netto C.F., and Zangrossi-Jr H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23 (1998) 237-246
31. Gray J.A. Anxiety as a paradigm case of emotion. Br Med Bull 37 2 (1981) 193-197
32. Gray J.A., and McNaughton N. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 61 3 (2000) 161-176
33. Guimarães F.S., De Aguiar J.C., Del Bel E.A., and Ballejo G. Anxiolytic effect of nitric oxide synthase inhibitor microinjected into the dorsal central grey. Neuroreport 5 (1994) 1929-1932
34. Guimarães F.S., Beijamini V., Moreira F.A., Aguiar D.C., and de Lucca A.C. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29 8 (2005) 1313-1322
35. Harooni H.E., Naghdi N., Sepehri H., and Rohani A.H. The role of hippocampal nitric oxide (NO) on learning and immediate, short- and long-term memory retrieval in inhibitory avoidance task in male adult rats. Behav Brain Res 201 1 (2009) 166-172
36. Jacobsen L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Review 12 (1991) 118-134
37. Jay T.M., and Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313 4 (1991) 574-586
38. Kim C., Kim C.C., Kim J.K., Kim M.S., Chang H.K., Kim J.Y., et al. Fear response and aggressive behavior of hippocampectomized house rats. Brain Res 29 2 (1971) 237-251
39. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., Moser E.I., and Moser M.B. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA 99 16 (2002) 10825-10830
40. Kurt M., Bilge S.S., Aksoz E., Kukula O., Celik S., and Kesim Y. Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol 56 3 (2004) 353-357
41. Leza J.C., Lizasoain I., Cuéllar B., Moro M.A., and Lorenzo P. Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol 353 3 (1996) 349-354
42. Maren S., and Fanselow M.S. Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J Neurosci 15 11 (1995) 7548-7564
43. Masood A., Banerjee B., Vijayan V.K., and Ray A. Modulation of stress-induced neurobehavioral changes by nitric oxide in rats. Eur J Pharmacol 458 1-2 (2003) 135-139
44. McHugh S.B., Deacon R.M., Rawlins J.N., and Bannerman D.M. Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci 118 1 (2004) 63-78
45. Monzón M.E., Varas M.M., and De Barioglio S.R. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 22 7 (2001) 1043-1047
46. Moore P.K., and Handy R.L. Selective inhibitors of neuronal nitric oxide synthase-is no NOS really good NOS for the nervous system?. Trends Pharmacol Sci 18 6 (1997) 204-211
47. Moser M.B., and Moser E.I. Functional differentiation in the hippocampus. Hippocampus 8 6 (1998) 608-619
48. Nascimento Häckl L.P., and Carobrez A.P. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats. Neurobiol Learn Mem 88 2 (2007) 177-185
49. Paige J.S., and Jaffrey S.R. Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions. Curr Top Med Chem 7 1 (2007) 97-114
50. Pentkowski N.S., Blanchard D.C., Lever C., Litvin Y., and Blanchard R.J. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats. Eur J Neurosci 23 8 (2006) 2185-2196
51. Petrovich G.D., Canteras N.S., and Swanson L.W. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Brain Res Rev 38 1-2 (2001) 247-289
52. Pinheiro S.H., Zangrossi-Jr H., Del-Ben C.M., and Graeff F.G. Elevated mazes as animal models of anxiety: effects of serotonergic agents. An Acad Bras Cienc 79 (2007) 71-85
53. Pitkanen A., Jolkkonen E., and Kemppainen S. Anatomic heterogeneity of the rat amygdaloid complex. Folia Morphol (Warsz) 59 1 (2000) 1-23
54. Richmond M.A., Yee B.K., Pouzet B., Veenman L., Rawlins J.N., Feldon J., et al. Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial learning. Behav Neurosci 113 6 (1999) 1189-1203
55. Risold P.Y., and Swanson L.W. Structural evidence for functional domains in the rat hippocampus. Science 272 5267 (1996) 1484-1486
56. Roohbakhsh A., Moghaddam A.H., Massoudi R., and Zarrindast M.R. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol 34 3 (2007) 223-229
57. Spiacci Jr. A., Kanamaru F., Guimarães F.S., and Oliveira R.M. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav 88 3 (2008) 247-255
58. Susswein A.J., Katzoff A., Miller N., and Hurwitz I. Nitric oxide and memory. Neuroscientist 10 2 (2004) 153-162
59. Swanson L.W., and Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J Comp Neurol 172 1 (1977) 49-84
60. Tan S.E. Roles of hippocampal nitric oxide and calcium/calmodulin-dependent protein kinase II in inhibitory avoidance learning in rats. Behav Pharmacol 18 1 (2007) 29-38
61. Trivedi M.A., and Coover G.D. Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze. Neurobiol Learn Mem 81 3 (2004) 172-184
62. Vale A.L., Green S., Montgomery A.M., and Shafi S. The nitric oxide synthesis inhibitor l-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test. J Psychopharmacol 12 3 (1998) 268-272
63. Valtschanoff J.G., Weinberg R.J., Kharazia V.N., Nakane M., and Schmidt H.H. Neurons in rat hippocampus that synthesize nitric oxide. J Comp Neurol 331 1 (1993) 111-121
64. Verwer R.W., Meijer R.J., Van Uum H.F., and Witter M.P. Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus 7 4 (1997) 397-402
65. Viana M.B., Tomaz C., and Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49 (1994) 549-554
66. Volke V., Köks S., Vasar E., Bourin M., Bradwein J., and Männistö P.T. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport 6 10 (1995) 1413-1420
67. Wendland B., Schweizer F.E., Ryan T.A., Nakane M., Murad F., Scheller R.H., et al. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc Natl Acad Sci USA 91 6 (1994) 2151-2155
68. Zarrindast M.R., Babapoor-Farrokhran S., Babapoor-Farrokhran S., and Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 82 23-24 (2008) 1175-1181